A traditional Mongolian herbal medicine called Eligengurigumu-7 reduced fatty liver disease in laboratory mice by activating a cellular pathway called PPAR signaling that helps the body burn fat more efficiently. According to research reviewed by Gram, the herb’s key ingredient cosmosiin showed particularly strong protective effects on liver cells. While these findings are promising, human studies have not yet been conducted, so this treatment remains experimental and should not replace current medical care for fatty liver disease.
Researchers studied a traditional Mongolian herbal medicine called Eligengurigumu-7 (GRGM-7) to see if it could treat non-alcoholic fatty liver disease, a condition where fat builds up in the liver. Using mice and lab cells, scientists found that the herb worked by activating a specific pathway in the body that helps break down fat and keep the liver healthy. One key ingredient in the herb, called cosmosiin, appeared especially powerful at protecting liver cells. The findings suggest this ancient remedy could become a modern treatment for a disease that affects millions of people worldwide.
Key Statistics
A 2026 laboratory study found that Eligengurigumu-7, a Mongolian herbal medicine, reduced fatty liver disease in mice by activating the PPAR signaling pathway, which controls how the body breaks down and uses fat.
Research on Eligengurigumu-7 identified cosmosiin, a naturally occurring plant compound within the herb, as showing high affinity for key targets involved in fatty liver disease progression and demonstrating favorable protective effects on liver cells.
In laboratory experiments, combining Eligengurigumu-7 with fenofibrate, a pharmaceutical drug that activates PPAR signaling, produced greater improvements in metabolic abnormalities than either treatment alone, suggesting complementary mechanisms of action.
The Quick Take
- What they studied: Whether a traditional Mongolian herbal medicine could treat fatty liver disease by activating a specific fat-burning pathway in the body.
- Who participated: Laboratory mice fed either high-fat diets or special diets lacking certain nutrients, plus liver cells grown in dishes and treated with fatty acids to mimic the disease.
- Key finding: The herbal medicine GRGM-7 successfully reduced fat buildup in mouse livers and protected liver cells by activating a pathway called PPAR signaling, which helps the body burn fat more efficiently.
- What it means for you: This research suggests a plant-based treatment option for fatty liver disease might be possible, though human studies are still needed before doctors could prescribe it. People with fatty liver disease should continue following their doctor’s current treatment recommendations.
The Research Details
Scientists conducted a comprehensive investigation using multiple research methods. First, they analyzed genetic data from patients with fatty liver disease to identify which genes and pathways were most important in the disease. Then they created mouse models of fatty liver disease using two different methods: feeding mice high-fat diets or special nutrient-deficient diets. They treated some mice with different doses of the Mongolian herbal medicine GRGM-7 and compared results to untreated mice. The researchers also grew liver cells in laboratory dishes, exposed them to fatty acids to create a disease-like state, and tested how the herb and its individual ingredients affected these cells. Finally, they used advanced techniques to identify which specific compounds from the herb were absorbed into the bloodstream and how these compounds interacted with key targets in the body.
This multi-layered approach is important because it moves from basic science to practical testing. By studying both living animals and isolated cells, researchers can understand how the herb works at different levels. Testing multiple methods of creating fatty liver disease helps confirm that results aren’t just due to one specific cause. Identifying which specific ingredients are actually absorbed into the bloodstream is crucial because it shows which compounds are likely responsible for the herb’s effects.
The study used rigorous scientific methods including genetic sequencing, molecular imaging, and multiple validation techniques. Researchers confirmed their findings using different experimental approaches, which strengthens confidence in the results. However, the study was conducted entirely in animals and cells, not humans, so results may not directly translate to people. The sample size for animal studies was not specified in the abstract, making it difficult to assess statistical power. Publication in a peer-reviewed journal suggests the work met scientific standards, though independent verification would be valuable.
What the Results Show
The herbal medicine GRGM-7 successfully reduced fatty liver disease in mice that were fed high-fat diets or nutrient-deficient diets. The herb worked by activating a cellular pathway called PPAR signaling, which helps the body break down and use fat more efficiently. When researchers turned off key genes in this pathway, the herb’s protective effects were reduced, confirming that PPAR signaling was essential to how the medicine worked. The herb also improved multiple markers of liver health, including reducing fat accumulation and improving how the liver processes nutrients.
A specific compound within the herb called cosmosiin showed particularly strong effects at protecting liver cells in laboratory dishes. When researchers combined the herbal medicine with a pharmaceutical drug that also activates PPAR signaling, the effects were even stronger than either treatment alone. This suggests the herb works through multiple mechanisms that complement each other. The research identified ATP citrate lyase (ACLY), a protein involved in fat production, as a key target through which the herb exerts its protective effects.
This research builds on existing knowledge that PPAR signaling is important in fatty liver disease. Previous studies have shown that activating this pathway helps reduce liver fat, and this study confirms that a traditional herbal medicine can activate this same pathway. The finding that cosmosiin, a naturally occurring plant compound, can activate PPAR signaling adds to growing evidence that plant-derived compounds may offer therapeutic benefits for metabolic diseases. The combination of traditional medicine knowledge with modern molecular biology represents an emerging approach to drug discovery.
This study was conducted entirely in laboratory animals and cells, not in humans, so results may not directly apply to people. The specific number of mice and cells tested was not provided, making it impossible to assess whether the sample sizes were adequate. The study did not test the herb’s safety or whether it might interact with other medications. Long-term effects in living animals were not evaluated. The research focused on one specific herbal formulation, so results may not apply to other preparations or individual ingredients used separately.
The Bottom Line
Based on this research, Gram Research analysis suggests that GRGM-7 shows promise as a potential treatment for fatty liver disease, though confidence is moderate since human studies have not yet been conducted. People currently diagnosed with fatty liver disease should continue following their doctor’s recommendations, which typically include weight loss, reducing sugar intake, and limiting alcohol. This herbal medicine should not be used as a replacement for established medical treatments without consulting a healthcare provider. Anyone interested in trying herbal treatments should discuss this with their doctor, especially if they take other medications.
This research is most relevant to people with non-alcoholic fatty liver disease, a condition affecting roughly 25 percent of the global population. Researchers and pharmaceutical companies developing new treatments should pay attention to these findings. People with metabolic conditions like obesity or type 2 diabetes, which often accompany fatty liver disease, may find this research interesting. Healthcare providers treating liver disease should be aware of this emerging research. People should not self-treat based on this study alone, as human safety and efficacy data are not yet available.
In the animal studies, the herb showed protective effects within the timeframe of the experiments, typically several weeks. However, translating these results to humans would require clinical trials lasting months to years to determine appropriate dosing, safety, and effectiveness. Even if human trials begin soon, it would likely take 5 to 10 years before this treatment could potentially become available as a prescription medication. In the meantime, established approaches like diet changes and exercise remain the most evidence-based treatments for fatty liver disease.
Frequently Asked Questions
Can I use Mongolian herbal medicine to treat fatty liver disease?
This herbal medicine shows promise in laboratory studies, but human trials have not been conducted yet. Current evidence-based treatments include weight loss, reducing sugar intake, and limiting alcohol. Consult your doctor before trying any herbal treatment, especially if you take other medications.
How does Eligengurigumu-7 work to treat fatty liver?
The herb activates a cellular pathway called PPAR signaling that helps your body burn fat more efficiently and maintain healthy liver fat levels. It also targets a protein called ACLY that’s involved in fat production, reducing overall fat accumulation in liver cells.
What is cosmosiin and why is it important?
Cosmosiin is a naturally occurring plant compound found in Eligengurigumu-7 that showed particularly strong protective effects on liver cells in laboratory studies. It appears to be one of the key active ingredients responsible for the herb’s hepatoprotective effects.
When will this herbal medicine be available as a treatment?
This research is still in early stages using animals and cells. Human clinical trials would need to be conducted first, which typically takes 5 to 10 years before a treatment could become available as a prescription medication. Established lifestyle changes remain the most proven approach today.
Is this herbal medicine safe for people with fatty liver disease?
Safety has not been tested in humans yet. This study only evaluated effectiveness in animals and cells. Before any herbal treatment could be recommended, researchers would need to conduct human trials to determine appropriate doses, potential side effects, and interactions with other medications.
Want to Apply This Research?
- Users interested in fatty liver disease management could track liver enzyme levels (ALT and AST) from blood tests every 3 months, along with weight and waist circumference weekly, to monitor disease progression and response to lifestyle changes.
- Users could set daily reminders to log meals and identify high-fat, high-sugar foods to reduce, since diet is the primary modifiable factor in fatty liver disease. The app could provide recipes and meal plans aligned with liver-healthy eating patterns.
- Establish a quarterly check-in system where users log their latest liver function test results, weight, and symptoms. The app could display trends over 6 to 12 months to show whether lifestyle modifications are improving liver health markers.
This research describes laboratory and animal studies of a traditional herbal medicine for fatty liver disease. These findings have not been tested in humans, and the herbal medicine is not approved by regulatory agencies for treating any condition. This article is for educational purposes only and should not be considered medical advice. People with fatty liver disease should continue following their doctor’s current treatment recommendations, which typically include weight loss, dietary changes, and regular monitoring. Do not start, stop, or change any treatment without consulting your healthcare provider. If you are interested in herbal treatments, discuss this with your doctor, especially if you take other medications, as herbal products can interact with pharmaceuticals. This research represents early-stage scientific investigation and should not be used as a basis for self-treatment decisions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.